Pathogenic mechanisms and clinical implications of congenital neutropenia syndromes

F Hauck, C Klein - Current opinion in allergy and clinical …, 2013 - journals.lww.com
Advanced genetic and biochemical techniques have helped to expand our knowledge of
congenital neutropenia syndromes. Known and novel genetic entities shed light on …

HAX‐1: A family of apoptotic regulators in health and disease

SV Yap, JM Koontz… - Journal of cellular …, 2011 - Wiley Online Library
HAX‐1 comprises a family of ubiquitously expressed proteins that play important roles in the
regulation of programmed cell death. Herein, we provide a comprehensive review of the …

Incidence of severe congenital neutropenia in Sweden and risk of evolution to myelodysplastic syndrome/leukaemia

G Carlsson, A Fasth, E Berglöf… - British journal of …, 2012 - Wiley Online Library
Severe congenital neutropenia (SCN) is characterized by low blood neutrophil counts, early
bacterial infections, and risk of leukaemia development. As yet, no population‐based …

Mutations in the ELANE Gene are Associated with Development of Periodontitis in Patients with Severe Congenital Neutropenia

Y Ye, G Carlsson, B Wondimu, A Fahlén… - Journal of clinical …, 2011 - Springer
Background Patients with severe congenital neutropenia (SCN) often develop periodontitis
despite standard medical and dental care. In light of previous findings that mutations in the …

Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes

P Blombery, LC Fox, GL Ryland, ER Thompson… - …, 2020 - pmc.ncbi.nlm.nih.gov
Bone marrow failure (BMF) related to hypoplasia of hematopoietic elements in the bone
marrow is a heterogeneous clinical entity with a broad differential diagnosis including both …

Hax-1: a regulator of calcium signaling and apoptosis progression with multiple roles in human disease

T Simmen - Expert opinion on therapeutic targets, 2011 - Taylor & Francis
Introduction: Hax-1, the hematopoietic cell-specific protein-associated protein X-1, is an
inhibitor of apoptosis, which has been implicated in severe congenital neutropenia (SCN) …

Different pattern of gene mutations in Iranian patients with severe congenital neutropenia (including 2 new mutations)

Z Alizadeh, MR Fazlollahi, M Houshmand… - Iranian Journal of …, 2013 - ijaai.tums.ac.ir
Severe congenital neutropenia (SCN) is a rare primary immunodeficiency disease. Different
genes are found to be associated with SCN, including ELA2, HAX1, WAS, GFI1, G-CSFR …

A novel HAX1 gene mutation in severe congenital neutropenia (SCN) associated with neurological manifestations

M Faiyaz-Ul-Haque, A Al-Jefri, F Al-Dayel… - European journal of …, 2010 - Springer
Autosomal recessive severe congenital neutropenia (SCN) results from a maturation arrest
of granulopoiesis at the level of promyelocytes and apoptosis of myeloid cells. In SCN …

[HTML][HTML] Novel HAX1 gene mutations associated to neurodevelopment abnormalities in two Italian patients with severe congenital neutropenia

M Lanciotti, S Indaco, S Bonanomi, T Coliva… - …, 2010 - ncbi.nlm.nih.gov
We read with interest the recent perspective article by Klein. 1 Genetic analysis in
individuals with severe congenital neutropenia (SCN) indicates that 60% of cases were …

[HTML][HTML] A novel compound heterozygous HAX1 mutation in a Chinese patient with severe congenital neutropenia and chronic myelomonocytic leukemia …

SL Xue, JL Li, JY Zou, J Su, SN Chen, DP Wu - Haematologica, 2012 - ncbi.nlm.nih.gov
Severe congenital neutropenia (SCN) is a rare disease, comprising a heterogeneous group
of inherited disorders. Clinical features include reduced absolute neutrophil counts from …